The term PTPλ Activators would refer to a class of compounds that modulate the activity of a protein tyrosine phosphatase designated as PTPλ, assuming such a protein exists and is recognized within the biochemical nomenclature. Protein tyrosine phosphatases (PTPs) are enzymes that remove phosphate groups from tyrosine residues on proteins, a key step in the regulation of signal transduction pathways. Activators of a PTP, in this case, PTPλ, would be molecules that increase the enzyme's phosphatase activity. The design and discovery of such activators would necessitate a deep understanding of the enzyme's structure, including the active site where dephosphorylation occurs, as well as any allosteric sites that might be present. Activators could function by enhancing the enzyme's affinity for its substrates, stabilizing the active conformation of the enzyme, or by other mechanisms that lead to an increase in its catalytic activity. The development of these molecules would involve iterative cycles of design, synthesis, and testing, guided by the principles of medicinal chemistry and enzyme kinetics.
Experimentally, the identification of PTPλ activators would likely involve a combination of in vitro enzyme assays and structure-activity relationship (SAR) studies. Initial screening might use colorimetric or fluorometric assays to detect the presence of free phosphate, indicating increased enzymatic activity in the presence of potential activators. Further characterization would involve kinetic analyses to determine how these molecules affect parameters such as Km (Michaelis constant) and Vmax (maximum velocity) of the PTPλ-catalyzed reaction. To understand the interaction between PTPλ and its activators at a molecular level, biophysical studies such as isothermal titration calorimetry (ITC), surface plasmon resonance (SPR), or X-ray crystallography might be employed. These techniques would help elucidate the binding affinity, thermodynamics, and structural basis of activation. Additionally, computational modeling and molecular dynamics simulations could provide insights into the conformational changes induced by activator binding and predict the impact of molecular modifications on the potency and specificity of these compounds. By advancing the understanding of PTPλ and its regulation, such studies contribute to the foundational knowledge of protein tyrosine phosphatase function and regulation within the context of cellular signaling networks.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has been shown to affect signaling pathways and might modulate the expression of PTPs as part of a regulatory mechanism. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
As a regulator of gene expression, retinoic acid might affect PTP expression during cellular differentiation and development. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
It can cause epigenetic changes that may lead to altered expression of a range of genes, potentially including PTPs. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
A cAMP analog that may modulate gene expression through PKA activation and downstream signaling effects. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, which can lead to transcriptional changes in various genes, including potentially PTPs. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Activates Nrf2, a transcription factor that might influence the expression of a variety of genes, including PTPs. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Known to interact with multiple signaling pathways, which could conceivably result in modulation of PTP expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Affects GSK-3 and Wnt signaling, which may have downstream effects on the expression of various proteins, including PTPs. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate many signaling pathways, potentially influencing the expression of genes like PTPs. | ||||||
Piperine | 94-62-2 | sc-205809 sc-205809A | 5 g 25 g | $37.00 $146.00 | 3 | |
May enhance the bioavailability of other compounds and has been suggested to affect various signaling pathways. | ||||||